Dulce C.
- Country
- Spain
- Department
- Neurology
Research Overview
- A Multicenter, Open-label, Long-term, Safety, Tolerability, and Efficacy Study of XEN1101 in Subjects Diagnosed With Epilepsy (X-TOLE4)
- Efficacy and Safety Evaluation of PRAX-628 in Adults with Focal Epilepsy: A Double-Blind, Randomized, Multicenter Trial
- Evaluation of BHV-7000 as Adjunctive Therapy in Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures: A Randomized, Double-blind, Placebo-controlled Study
Data & Insights
Has run more than one trial at 113 of 162 partner sites.
Specializations
Neurological Disorders
The investigator specializes in studying and treating refractory focal onset epilepsy, contributing to the advancement of therapeutic approaches for patients with drug-resistant seizure disorders.
- Epilepsy Management
- Seizure Control
- Neurological Therapeutics
Their research extends to evaluating novel therapeutic compounds for patients who have not responded adequately to existing anti-epileptic treatments.
Treatment-Resistant Conditions
The investigator focuses on developing solutions for treatment-resistant neurological conditions, with particular emphasis on patients who have not responded to conventional therapeutic approaches.
- Refractory Conditions
- Drug Resistance
- Alternative Therapeutic Options
Their work encompasses the evaluation of safety and tolerability profiles of emerging therapeutic agents in adult populations.
Clinical Safety Assessment
The investigator specializes in conducting comprehensive safety and tolerability evaluations of investigational treatments, particularly in the context of neurological disorders.
- Safety Monitoring
- Therapeutic Assessment
- Patient Safety Protocols
Their expertise includes thorough evaluation of new therapeutic compounds in adult patients with complex neurological conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.